MtoZ Biolabs Releases Protein N-terminal Sequencing Technique

publication date: Aug 31, 2018
author/source: MtoZ Biolabs


MtoZ Biolabs, an international contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services, announce that it has launched an updated platform for protein n-terminal sequencing.

This sophisticated N-T sequencing platform consisting of Edman sequencing and protein N-T de novo sequencing with their advantages complementary to each other.

Protein expression starts at the N terminus, and the n terminal sequence of protein plays an important role in protein function, protein stability, and localization in cells. Therefore, N-terminal sequence analysis of proteins can provide important evidence for protein function and localization.

Edman Degradation Sequencing

There are three steps in Edman sequencing. Firstly, PITC (phenylisothiocyanate) is added to the N-terminal of a peptide/protein under mild alkaline condition. Secondly, the PITC conjugated N-terminal amino acid is cleaved as a thiazolinone derivative under acidic conditions. Finally, the PITC-AA is converted to PTH-AA (phenylisothiocyanate amino acid derivative) which is more stable, and identified by chromatography. Meanwhile, the cycle of PITC creation is repeated for identification of the next amino acid. 

Mass Spectrometry Analysis

The principle of mass spectrometry is to digest the protein by trypsin, and directly measure the peptide mixture by tandem mass spectrometry, and then select the N-terminal peptide ion by mass spectrometry for Tandem mass spectrometry to obtain the N terminal sequence. It is able to sequence mixed proteins, terminally blocked or glycosylated proteins.

“As a well-established sequencing method, Edman sequencing provides more accurate protein sequence data, compared to MS”, said Mrs Prime Jones, marketing manager of MtoZ Biolabs, “Our protein or peptide N-terminal sequence analysis service is performed by SHIMADZU PPSQ-33A Analyzer and Obitrap Fusion Lumos Analyzer, equipped with the newest HPLC analysis system.”


Platform Features

Obitrap Fusion Lumos System

Platform Features

Sequencing Highlights

About MtoZ Biolabs

MtoZ Biolabs is specialized in quantitative multiplexed proteomics and metabolomics applications through the establishment of state-of-the-art mass spectrometry platforms, coupled with high-performance liquid chromatography technology. It is also committed to developing efficient, and effective tools for addressing core bioinformatics problems.

more from this company

If you have not logged into the website then please enter your details below.



Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd


Previous | Next